Odyssey Thera, Inc.

Odyssey Thera was founded over ten years ago with the goal of transforming drug discovery through deep cellular analysis. Odyssey's patented technologies measure disease-relevant pathway activity within living human cells. Unprecedented throughput and breadth of high-content assays enables assessment of key signaling nodes as well as the cellular system, allowing for rapid identification of drug candidates with optimal efficacy and safety profiles. The Company's leadership position in fundamental patents, technology, and know-how relating to cellular analysis has led to alliances with Pfizer, Abbott, Merck, the U.S. EPA, and others.